Evidence map›Paper›PMID 30271494›Full record

ArticleJournal of Cancer2018

Prognostic Role of MicroRNA-497 In Cancer Patients: A Meta-analysis.

Jiaxi Feng, Xi Gu, Liyang Liu, Ming Lu, Xiang Ma, Yang Cao, Rongjiang Jiang, Baolin Wang, Qinghong Zhao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma.Canadian journal of gastroenterology & hepatology · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiaxi FengDepartment of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Xi GuDepartment of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Liyang LiuDepartment of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Ming LuDepartment of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Xiang MaDepartment of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Yang CaoDepartment of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Rongjiang JiangDepartment of Urology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Baolin WangDepartment of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Qinghong ZhaoDepartment of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkercancermeta-analysismicroRNA-497prognosis

Identifiers

PMID30271494
PMCPMC6160686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.